Pubblicazioni

Real-life comparison of nilotinib versus dasatinib as second-line therapy in chronic phase chronic myeloid leukemia patients

2021 - ANNALS OF HEMATOLOGY
Scalzulli, E.; Caocci, G.; Efficace, F.; Rizzo, L.; Colafigli, G.; Di Prima, A.; Pepe, S.; Fegatelli, D. A.; Carmosino, I.; Diverio, D.; Latagliata, R.; La Nasa, G.; Martelli, M.; Foa, R.; Breccia, M.

Longitudinal changes of endocrine and bone disease in adults with β-thalassemia major receiving different iron chelators over 5 years

2016 - ANNALS OF HEMATOLOGY
Poggi, Maurizio; Sorrentino, Francesco; Pugliese, Pellegrina; Smacchia, Maria Paola; Daniele, Carmine; Equitani, Francesco; Terlizzi, Filomena; Guitarrini, Maria Rita; Monti, Salvatore; Maffei, Laura; Losardo, Anna; Pasin, Methap; Toscano, Vincenzo

Real-life use of erythropoiesis-stimulating agents in myelodysplastic syndromes. a “Gruppo Romano Mielodisplasie (GROM)” multicenter study

2016 - ANNALS OF HEMATOLOGY
Buccisano, Francesco; Piccioni, Anna Lina; Nobile, Carolina; Criscuolo, Marianna; Niscola, Pasquale; Tatarelli, Caterina; Fianchi, Luana; Villivà, Nicoletta; Neri, Benedetta; Carmosino, Ida; Gumenyuk, Svitlana; Mancini, Stefano; Voso, Maria Teresa; Maurillo, Luca; Breccia, Massimo; Zini, Gina; Venditti, Adriano; Fenu, Susanna; Spiriti, Maria Antonietta Aloe; Latagliata, Roberto

Specific scoring systems to predict survival of patients with high-risk myelodysplastic syndrome (MDS) and de novo acute myeloid leukemia (AML) after intensive antileukemic treatment based on results of the EORTC-GIMEMA AML-10 and intergroup CRIANT studies

2015 - ANNALS OF HEMATOLOGY
Oosterveld, M; Suciu, S; Muus, P; Germing, U; Delforge, M; Belhabri, A; Aul, C; Selleslag, D; Ferrant, A; Marie, Jp; Amadori, S; Jehn, U; Mandelli, F; Hess, U; Hellström-Lindberg, E; Cakmak-Wollgast, S; Vignetti, M; Labar, B; Willemze, R; de Witte, T.

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma